Expression of cancer stem cell markers in basal and penta-negative breast carcinomas – A study of a series of triple-negative tumors-Reference-Cited by-同舟云学术

Expression of cancer stem cell markers in basal and penta-negative breast carcinomas – A study of a series of triple-negative tumors

Published:2014-07 Issue:7 Volume:210 Page:432-439
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

de Mendonça Uchôa Diego,Graudenz Marcia Silveira,Callegari-Jacques Sidia Maria,Hartmann Carolina Rigatti,Ferreira Bruna Pellini,Fitarelli-Kiehl Mariana,Edelweiss Maria Isabel

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference61 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc. Natl. Acad. Sci. U. S. A.,2001

3. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc. Natl. Acad. Sci. U. S. A.,2003

4. Histopathology of primary breast cancer;Viale;Breast,2003

5. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma;Nielsen;Clin. Cancer Res.,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness;Cancers;2022-09-01

2. Prognosis assessment of CD44+/CD24− in breast cancer patients: a systematic review and meta-analysis;Archives of Gynecology and Obstetrics;2022-04-18

3. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead;Frontiers in Oncology;2021-08-09

4. KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer;Breast Cancer Research and Treatment;2020-10-14

5. EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT;Siberian journal of oncology;2020-09-02